Fulcrum Asset Management’s NeoGenomics NEO Stock Holding History

Fulcrum Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82K	Buy	+128	New	+$1.24K	﹤0.01%	891

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Fulcrum Asset Management's NEO Position: Q2 2026 in Review

Fulcrum Asset Management opened a new position in NeoGenomics (NEO) in Q2 2026: 128 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #891 among its holdings.

266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Fulcrum Asset Management held 128 shares of NeoGenomics worth $1.82K as of Q2 2026.
NeoGenomics was a new Fulcrum Asset Management position in Q2 2026.
NeoGenomics made up ﹤0.01% of Fulcrum Asset Management's portfolio in Q2 2026, its #891 holding.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.